metabolic disorder

(redirected from Metabolic disease)
Also found in: Dictionary, Thesaurus, Medical, Legal.
Related to Metabolic disease: Metabolic Bone Disease

metabolic disorder

[‚med·ə′bäl·ik dis′ȯrd·ər]
(medicine)
Any disorder that involves an alteration in the normal metabolism of carbohydrates, lipids, proteins, water, and nucleic acids; evidenced by various syndromes and diseases.
References in periodicals archive ?
The Genzyme drug discovery effort that developed the anti-obesity program has drawn upon the company's extensive expertise in developing compounds to treat metabolic disease and its world-renowned reputation in polymer chemistry.
The last chapter is very important because it provides a comprehensive review of the treatments of inherited metabolic diseases.
How do the prices of metabolic disease therapies in Europe and Japan compare with U.
a privately held biotechnology company, is a leading provider of research tools for the study of human metabolic disease.
Earlier this year, 25 international medical organizations and more than 60 leading experts in diabetes and metabolic disease including the ASMBS, ADA, NAASO - The Obesity Society, and The European Association for the Study of Diabetes (EASD) convened in Rome, Italy for a summit and consensus conference to review the medical evidence on the effects of gastrointestinal operations on diabetes.
Elixir is a pharmaceutical company focused on the discovery, development and commercialization of novel pharmaceuticals for the treatment of metabolic diseases such as diabetes and obesity.
A major peer-reviewed article in the current issue of Nature Reviews Drug Discovery describes the intimate links between these pathways of aging and those of metabolic disease, such as type 2 diabetes and obesity.
Elixir has filed multiple patents on its ghrelin antagonists, with claims that include composition of matter across several different chemical classes, as well as uses of these compounds in a variety of diseases of aging, including metabolic disease.
This report answers the following questions: - What are the near term business opportunities in the diabetes, obesity and metabolic disease market?
Elixir's product pipeline includes a number of programs which the Company believes will have significant advantages over existing products and will address unmet medical needs of the large metabolic disease markets.